FI58498C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-amino-6-metyl-4h-pyran-5-karboxylsyraestrar - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-amino-6-metyl-4h-pyran-5-karboxylsyraestrar Download PDF

Info

Publication number
FI58498C
FI58498C FI2263/73A FI226373A FI58498C FI 58498 C FI58498 C FI 58498C FI 2263/73 A FI2263/73 A FI 2263/73A FI 226373 A FI226373 A FI 226373A FI 58498 C FI58498 C FI 58498C
Authority
FI
Finland
Prior art keywords
pyran
methyl
acid ethyl
amino
ethyl ester
Prior art date
Application number
FI2263/73A
Other languages
English (en)
Finnish (fi)
Other versions
FI58498B (fi
Inventor
Horst Meyer
Friedrich Bossert
Wulf Vater
Kurt Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to FI792730A priority Critical patent/FI57944C/fi
Application granted granted Critical
Publication of FI58498B publication Critical patent/FI58498B/fi
Publication of FI58498C publication Critical patent/FI58498C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/20—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D309/22—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
FI2263/73A 1972-07-19 1973-07-17 Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-amino-6-metyl-4h-pyran-5-karboxylsyraestrar FI58498C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI792730A FI57944C (fi) 1972-07-19 1979-09-03 Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-amino-6-metyl-4-nitrofenyl-4h-pyraner

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2235406A DE2235406C3 (de) 1972-07-19 1972-07-19 2-Amino-4H-pyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2235406 1972-07-19

Publications (2)

Publication Number Publication Date
FI58498B FI58498B (fi) 1980-10-31
FI58498C true FI58498C (fi) 1981-02-10

Family

ID=5851048

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2263/73A FI58498C (fi) 1972-07-19 1973-07-17 Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-amino-6-metyl-4h-pyran-5-karboxylsyraestrar

Country Status (27)

Country Link
US (1) US3897462A (fr)
JP (2) JPS596873B2 (fr)
AT (3) AT326653B (fr)
AU (1) AU468904B2 (fr)
BE (1) BE802496A (fr)
BG (1) BG22828A3 (fr)
CA (1) CA999299A (fr)
CH (1) CH597216A5 (fr)
CS (2) CS174214B2 (fr)
DD (1) DD109381A5 (fr)
DE (1) DE2235406C3 (fr)
DK (1) DK132410C (fr)
ES (2) ES416988A1 (fr)
FI (1) FI58498C (fr)
FR (1) FR2192842B1 (fr)
GB (1) GB1402793A (fr)
HU (1) HU166811B (fr)
IE (1) IE38064B1 (fr)
IL (1) IL42745A (fr)
LU (1) LU68031A1 (fr)
NL (1) NL7309889A (fr)
NO (2) NO138656C (fr)
PL (2) PL95715B1 (fr)
RO (2) RO63583A (fr)
SE (1) SE399259B (fr)
SU (1) SU466682A3 (fr)
ZA (1) ZA734890B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5919019U (ja) * 1982-07-29 1984-02-04 株式会社吉野工業所 化粧品容器
DE4429786A1 (de) * 1994-08-23 1996-02-29 Bayer Ag Verwendung von substituierten 6-Amino-4H-pyranen
DE19529859A1 (de) * 1995-08-14 1997-02-20 Bayer Ag Verwendung von Acyl-substituierten Aminopyranen

Also Published As

Publication number Publication date
RO62811A (fr) 1977-11-15
ES442696A1 (es) 1977-04-16
AT328443B (de) 1976-03-25
NO138656C (no) 1978-10-18
NO139440C (no) 1979-03-14
FR2192842A1 (fr) 1974-02-15
AU468904B2 (en) 1976-01-29
IL42745A (en) 1976-12-31
SU466682A3 (ru) 1975-04-05
IE38064L (en) 1974-01-19
HU166811B (fr) 1975-06-28
PL90876B1 (fr) 1977-02-28
FR2192842B1 (fr) 1977-07-15
LU68031A1 (fr) 1973-09-17
ATA638873A (de) 1975-03-15
ES416988A1 (es) 1976-06-01
GB1402793A (en) 1975-08-13
DE2235406A1 (de) 1974-02-07
NO139440B (no) 1978-12-04
PL95715B1 (pl) 1977-11-30
ATA19475A (de) 1975-06-15
DK132410B (da) 1975-12-01
FI58498B (fi) 1980-10-31
NO138656B (no) 1978-07-10
BE802496A (fr) 1974-01-18
CH597216A5 (fr) 1978-03-31
IL42745A0 (en) 1973-10-25
CA999299A (en) 1976-11-02
AT326653B (de) 1975-12-29
NL7309889A (fr) 1974-01-22
DD109381A5 (fr) 1974-11-05
NO772996L (no) 1974-01-22
US3897462A (en) 1975-07-29
DE2235406B2 (de) 1981-01-22
JPS4955670A (fr) 1974-05-30
DK132410C (da) 1976-05-03
BG22828A3 (fr) 1977-04-20
RO63583A (fr) 1978-08-15
AU5825873A (en) 1975-01-23
CS174245B2 (fr) 1977-03-31
JPS597714B2 (ja) 1984-02-20
CS174214B2 (fr) 1977-03-31
DE2235406C3 (de) 1982-01-07
JPS596873B2 (ja) 1984-02-15
JPS56108784A (en) 1981-08-28
ZA734890B (en) 1974-06-26
SE399259B (sv) 1978-02-06
IE38064B1 (en) 1977-12-21

Similar Documents

Publication Publication Date Title
JPH0459312B2 (fr)
FR2673182A1 (fr) Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique.
FI58498C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-amino-6-metyl-4h-pyran-5-karboxylsyraestrar
JPS5921850B2 (ja) 新ナフタレン誘導体の製法
RU2222532C2 (ru) Соединения ряда бензофуроксана, способ их получения (варианты), фармацевтическая композиция, способ получения парентерального состава и способ лечения коронарных сердечных заболеваний
JPH0314312B2 (fr)
JPH036151B2 (fr)
IL43079A (en) 2-amino-1,4-dihydropyridines,their production and pharmaceutical compositions containing them
US5120736A (en) 4-methyl-5-(2-(4-phenylpiperazin-1-yl)ethyl)thiazole derivatives their method of preparation and the pharmaceutical compositions in which they are present
JPS5943460B2 (ja) ２−アミノ−６−ジアルキルアミノジヒドロピリジンの製造方法
FI57944C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-amino-6-metyl-4-nitrofenyl-4h-pyraner
FI87075B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 4,5-dihydro- och 3,4,5,6-tetrahydro-2h-oxazolo cykloalkylpyridinderivat.
FI90075C (fi) Foerfarande foer framstaellning av ett terapeutiskt aktivt 1,3,5-tritianderivat substituerat i position 2
CH631713A5 (fr) Derives de chromones a activite medicamenteuse et leur preparation.
US4218461A (en) 2,3-Dihydro-2-[(1H-imidazol-1-yl)-methylene]-1H-inden-1-ones
US3691169A (en) 2-(alkylthioalkyl)-1,2,3,4-tetrahydroisoquinolines
EP0221820B1 (fr) Dérivés de l'imino-3 pyridazine, procédé d'obtention et compositions pharmaceutiques en contenant
JP3049816B2 (ja) 強心薬
US4083976A (en) 10'-( ω-N)-1,4-Diazabicyclo(4,3,0)-alkanyl-lacyl) -phenothiazine compositions
US3998820A (en) 10'-[ω-N-/1,4-diazabicyclo(4,m,o)-alkanyl/-acyl]-phenothiazines, their acidic addition salts and quaternary salts, process for producing same and use
CH625249A5 (en) Process for the preparation of imidazothiazole derivatives
US4061772A (en) Derivatives of the 1,2-diarylethylene and pharmaceutical compositions thereof
US3733418A (en) Method of treating hyperlipemia using bis(substituted phenyl) acetals
KR830002275B1 (ko) 불소가 함유된 1, 4-디하이드로피리딘 화합물의 제조방법
WO1989012634A1 (fr) [(aryl-4-piperazinyl-1)-2 ethoxy]-3 p-cymene, les derives ortho, meta, para monosubstitues ou disubstitues sur le noyau phenyle dudit produit, le procede de preparation desdits derives, et les medicaments contenant lesdits composes comme principe actif